Home R&D Page 3

R&D

Real-world evidence demonstrates significant difference in fracture risk reduction for osteoporosis patients using gastro-resistant risedronate (Actonel® GR) when compared with those using alendronate IR oral bisphosphonate
Featured

Real-world evidence demonstrates significant difference in fracture risk reduction for osteoporosis patients using gastro-resistant risedronate (Actonel® GR) when compared with those using alendronate IR oral bisphosphonate

Dominic Cuthbert -
0
Lilly and Lycia to develop novel lysosomal targeting chimera degraders
Featured

Lilly and Lycia to develop novel lysosomal targeting chimera degraders

Dominic Cuthbert -
0
Shape and Roche enter AAV-based RNA editing tech collaboration
Featured

Shape and Roche enter AAV-based RNA editing tech collaboration

Dominic Cuthbert -
0
Genevant and Takeda to develop novel nonviral gene therapies for rare liver diseases
Featured

Genevant and Takeda to develop novel nonviral gene therapies for rare liver diseases

Dominic Cuthbert -
0
BMS to develop Exscientia’s AI-designed, immune-modulating drug candidate
Featured

BMS to develop Exscientia’s AI-designed, immune-modulating drug candidate

Dominic Cuthbert -
0
Completion of enrolment in the Phase 3 ReSTORE trial of Rezafungin for treatment of candidemia & invasive candidiasis
Featured

Completion of enrolment in the Phase 3 ReSTORE trial of Rezafungin for treatment of candidemia & invasive candidiasis

Dominic Cuthbert -
0
First patient dosed in Avacta’s AVA6000 Pro-Doxorubicin Phase I clinical trial
Featured

First patient dosed in Avacta’s AVA6000 Pro-Doxorubicin Phase I clinical trial

Tess Egginton -
0
Seagen and RemeGen enter agreement for novel HER2-targeted ADC
Featured

Seagen and RemeGen enter agreement for novel HER2-targeted ADC

Dominic Cuthbert -
0
Kite and Appia Bio to develop allogeneic cell therapies for cancer
Featured

Kite and Appia Bio to develop allogeneic cell therapies for cancer

Dominic Cuthbert -
0
Healx launches AI-powered indication expansion partnership with Ono Pharmaceutical Co. Ltd.
Featured

Healx launches AI-powered indication expansion partnership with Ono Pharmaceutical Co. Ltd.

Dominic Cuthbert -
0
1234...189Page 3 of 189

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks